China Market Intelligence

February 28th, 2023
By USCBC Staff

Many companies are preparing senior executive travel to China for the first time in several years now that China has eliminated quarantine requirements on inbound travelers. To better understand the different factors companies are considering in planning executive travel to China, USCBC conducted a short survey to help members benchmark against each other’s plans. Responses were collected from February 8 to 17, on the heels of the United States shooting down a Chinese surveillance balloon...

February 21st, 2023
By Craig Allen and David Thomas

US-China relations are at a difficult and highly uncertain inflection point. Vice President Kamala Harris and Secretary of State Antony Blinken participated in the Munich Security Conference February 17 to 19. Secretary Blinken and President Xi Jinping’s top foreign policy adviser, Wang Yi, reportedly had a tense private meeting during which both sides drew lines in the sand and did not appear to de-escalate the balloon incident as was hoped. During their meeting, we had hoped that Secretary...

February 15th, 2023
By Greyson Mann

Chinese investments throughout the United States are under increasing scrutiny, with once uncontroversial projects now receiving national attention. A growing number of state and local regulators are racing to create new tools to review and block such investments due to political and national security concerns. If passed, which USCBC believes is likely, these proposals are likely to restrict what kinds of business partnerships US companies can pursue with Chinese firms in the United States,...

February 15th, 2023
By Jason Zhou

This article updates USCBC’s December 2022 FAQs on China’s Cross-Border Data Transfer (CBDT) Regulation with new insights into company progress and likely enforcement patterns as the March 1 deadline approaches. This process is required only for companies seeking to transfer certain types or volumes of data outside of China. Please reference the earlier FAQ for basic questions about the other legally approved CBDT methods and applicable circumstances.

February 1st, 2023
By Banny Wang and Mingyue Li

It has been two months since China lifted its three-year-long zero-COVID policy. While hospitals nationwide remain overstretched with patients suffering severe symptoms, the majority of the population has recovered from the first wave of infections and is back on the road for the Chinese New Year. Without COVID-19 lockdowns hobbling growth, business sentiment on the ground has been steadily improving. 

February 1st, 2023
By Joseph Rafshoon

During the 118th Congress, all eyes will be on the newly established Select Committee on Strategic Competition Between the United States and the Chinese Communist Party. Still, it is important to note that the select committee will not have any legislative authority, and that the  standing committees will still hold full power to craft, introduce, and mark up legislation. With Republicans now in control of the House, many of those committees will lean even harder into China issues. While...

February 1st, 2023
By Zach Tomatz

China’s state-owned enterprises (SOEs) are an integral part of the country’s economic system, and their intimate ties to the government make them a key vehicle through which policymakers can influence economic outcomes. As such, SOEs are expected to play a critical role in China’s economic recovery, resiliency initiatives, and other plans such as decarbonization and dual circulation. SOEs have been subject to several systemic, ongoing reforms aimed at improving their commercial vitality,...

January 11th, 2023
By Felix Li and Ruiyue Sun

More than three years after the first COVID-19 case was reported, China has finally made a decisive u-turn, veering away from the zero-COVID regime and toward co-existing with the virus. On December 7, 2022, the National Health Commission (NHC) released 10 measures that effectively dismantled its stringent requirements.

January 11th, 2023
By Jackson Nemeth and John Clark

Last month, to the surprise and joy of many, China announced a major shift in its COVID-19 strategy, from prevention and control to treatment and openness. China relaxed a slew of restrictions, making it easier to travel to and within China. However, as a result of shifting its COVID-19 strategy, there has been a significant spike in the number of infections within China, with the number of cases reaching a record high in January. The United States and other countries, such as Australia,...

January 11th, 2023
By Erin Slawson and Annie Whitehurst

Skepticism and competition defined the US-China relationship for much of 2022—themes which are expected to continue to persist this year. With the tech competition intensifying and a renewed focus on China in the US Congress, this year will likely bring more uncertainty and continued challenges for multinational companies. However, with Secretary of State Antony Blinken planning to visit China early this year, in-person bilateral engagements between the two countries could help to soften...

Pages